Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of common stock ("Common Stock") outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the Securities and Exchange Commission ("SEC") on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The reported percentage is calculated based on 2,540,849 shares of Common Stock outstanding as of April 29, 2025, as reported on the Issuer's 10-Q filed with the SEC on May 1, 2025.


SCHEDULE 13G



 
ADVENT INTERNATIONAL, L.P.
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory
Date:05/15/2025
 
Advent International GPE VII LLC
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent-NCS Acquisition Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent-NCS GP LLC
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory
Date:05/15/2025
 
GPE VII GP Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
GPE VII GP (Delaware) Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent Partners GPE VII Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent Partners GPE VII-A Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent Partners GPE VII-B Cayman Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent Partners GPE VII Cayman Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent Partners GPE VII-A Cayman Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent International GPE VII Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent International GPE VII-A Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent International GPE VII-B Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent International GPE VII-C Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent International GPE VII-D Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent International GPE VII-E Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent International GPE VII-F Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent International GPE VII-G Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
 
Advent International GPE VII-H Limited Partnership
 
Signature:/s/ Neil Crawford
Name/Title:Neil Crawford / Authorized Signatory, See Exhibit 99.2
Date:05/15/2025
Exhibit Information

99.1 Joint Filing Agreement, dated May 15, 2025 99.2 Signature Page, dated May 15, 2025